We invest in 
Material and 

Energy and Environment

Energy efficiency ( Advanced materials, sensors, IoT )

Water treatment ( Membranes, sterilization, management technology )

Biomaterials ( Synthetic biology, specialty chemicals )


Biopharmaceuticals ( Chronic pain, rheumatoid arthritis, acute critical care, drug delivery )

Medical Technology ( Patient monitoring technologies, digital therapeutics )

Our Team

Create the future, together.

Phone: 650.853.1900
Fax:     650.853.8400
EMail:  cvc@om.asahi-kasei.co.jp
Menlo Park Office
4400 Bohannon Dr., Suite 240
Menlo Park, CA 94025 30 minutes to drive 16.5miles from SFO via US-101S.
Boston Office
269 Mill Road
Chelmsford, MA 01824 50 minutes to drive 30 miles from BOS via I-93N or US-3N.

Xeris Pharmaceuticals went public June 26th 2018
Xeris Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares https://www.xerispharma.com/news/

Mirexus Signs Strategic Partnership with Cargill Beauty April 12th 2018

PharmaIN and Shionogi Announce Collaboration and $17M Securities Purchase Agreements January 4th 2018

Katadyn Group to Acquire Hydro-Photon, Inc., Makers of SteriPEN July 21th 2017

Mirexus' Founder Dr. John Dutcher Receives University of Guelph Innovations of the Year Award. July 10th 2017

Axine Water Named to the 2017 Global Cleantech 100 January 23th 2017

Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO January 9th 2017

We launched our new website. August 15th 2016
We, Asahi Kasei Corporate Venture Capital, are very excited to announce the launch of our new website. We hope to find good partners having great possibilities. If you are also looking for a good partner, please contact us today!

Founded in 1920s, Asahi Kasei is a diversified business based in Tokyo focused on three primary sectors: Materials, Homes and Healthcare.

Asahi Kasei Corporate Venture Capital was established in 2008 and is focused on investing in innovative global companies in areas of strategic importance to Asahi Kasei. Our primary mission is to create new long-term business opportunities for Asahi Kasei. Our team, based in Menlo Park and the Boston area, consists of senior professionals with backgrounds in R&D, start up operations and venture capital.

Asahi Kasei invests across all stages. Our initial investment size can range from several hundred thousand dollars up to several million, depending on the opportunity. Given the right situation, Asahi Kasei can lead investments.

© 2019 Asahi Kasei